Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer.
Steensma DP, Molina R, Sloan JA, Nikcevich DA, Schaefer PL, Rowland KM Jr, Dentchev T, Novotny PJ, Tschetter LK, Alberts SR, Hogan TF, Law A, Loprinzi CL.
Steensma DP, et al. Among authors: schaefer pl.
J Clin Oncol. 2006 Mar 1;24(7):1079-89. doi: 10.1200/JCO.2005.02.7276.
J Clin Oncol. 2006.
PMID: 16505427
Clinical Trial.